Kagita, Sailaja <br/><br/>
Correlation of C/EBPα expression with response and resistance to imatinib in chronic myeloid leukaemia.  [electronic resource] 

 -  Japanese journal of clinical oncology  Aug 2015 
 - 749-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1465-3621 
<br/><br/><label>Standard No.: </label>10.1093/jjco/hyv064  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Benzamides--therapeutic use<br/>CCAAT-Enhancer-Binding Protein-alpha--metabolism<br/>Cell Differentiation<br/>Drug Resistance, Neoplasm<br/>Female<br/>Fusion Proteins, bcr-abl--metabolism<br/>Humans<br/>Imatinib Mesylate<br/>Isoleucine<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Middle Aged<br/>Mutation<br/>Piperazines--therapeutic use<br/>Predictive Value of Tests<br/>Prognosis<br/>Pyrimidines--therapeutic use<br/>Threonine